Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26544935.
- Also identified by DOI 10.1016/j.cell.2015.10.044 and PMC identifier 4638384.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two decades of studies in multiple model organisms have established the Hippo pathway as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ transcription co-activators, the Hippo pathway regulates cell proliferation, apoptosis, and stemness in response to a wide range of extracellular and intracellular signals, including cell-cell contact, cell polarity, mechanical cues, ligands of G-protein-coupled receptors, and cellular energy status. Dysregulation of the Hippo pathway exerts a significant impact on cancer development. Further investigation of the functions and regulatory mechanisms of this pathway will help uncovering the mystery of organ size control and identify new targets for cancer treatment.
Medical subject headings
- Neoplasms
- Organ Size
- Protein Serine-Threonine Kinases
- Signal Transduction